XNYS · Healthcare · Diagnostics & Research
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | Q2 2026 | 4.78 | 4.99 | +4.39% | $3.73B | ✅ Beat | -0.02% | +0.32% | +6.21% |
| 2026-04-30 | Q1 2026 | 4.11 | 4.25 | +3.41% | $3.54B | ✅ Beat | +1.60% | +0.49% | +1.27% |
| 2026-02-17 |
| Q4 2025 |
| 3.95 |
| 4.07 |
| +3.04% |
| $3.52B |
| ✅ Beat |
| +0.76% |
| +3.78% |
| -4.55% |
| 2025-10-28 | Q3 2025 | 4.13 | 4.18 | +1.21% | $3.56B | ✅ Beat | — | — | — |
| 2025-04-29 | Q1 2025 | 4.17 | 3.84 | -7.91% | $3.35B | ❌ Miss | +0.25% | +1.46% | +2.63% |
| 2025-02-06 | Q4 2024 | 3.39 | 3.45 | +1.77% | $3.33B | ✅ Beat | -0.59% | -1.16% | -1.46% |
| 2024-10-24 | Q3 2024 | 3.49 | 3.50 | +0.29% | $3.28B | ✅ Beat | -0.63% | -0.78% | +4.88% |
| 2024-08-01 | Q2 2024 | 3.78 | 3.94 | +4.23% | $3.22B | ✅ Beat | +1.12% | -3.71% | -1.58% |
Showing last 8 quarters.